Granules India Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1991

Chairman: Krishna Prasad Chigurupati

Managing Director: Krishna Prasad Chigurupati

Group: --

Listing: NSE: GRANULES, BSE: 532482

Headquarters: Hyderabad, Telangana

Website: www.granulesindia.com

Key Facts

Market cap: R 8,786.26 Cr

Revenue (TTM): R 2,897.56 Cr

Earnings (TTM): R 431.45 Cr

Cash: R 393.80 Cr

Total Debt: R 892.10 Cr

Promoters' ownership: 42.04%

Liquidity: High

52 Week range: R 114.10 - 438.00

Face value: R1.00

Shares outstanding: 24,76,74,796

10 Years Aggregate:

CFO: 1,501.02 Cr
EBITDA: 2,350.73 Cr
Net Profit: 1,128.41 Cr

Stock Performance

Trailing
Annual

Time Period	Granules India	S&P BSE Healthcare*	S&P BSE Mid Cap*
YTD	0.89	-0.69	3.38
1 month	-4.85	-0.39	4.93
3 months	-7.58	9.65	23.85
1 Year	133.90	52.26	17.12
3 Years	37.41	12.72	1.30
5 Years	24.15	6.52	12.65
10 Years	43.85	12.80	9.88

As on 27-Jan-2021 *As on 25-Jan-2021

Year	Granules India	S&P BSE Mid Cap	S&P BSE Healthcare
2020	188.88	19.87	61.45
2019	35.57	-3.05	-3.55
2018	-34.55	-13.31	-5.89
2017	27.21	48.13	0.49
2016	-28.21	7.97	-12.88
2015	78.88	7.43	15.06
2014	318.77	54.69	47.43

Annual Report (FY20)

Review & Analysis

Companies falling short of cash
Rajan Gulati . 16-May-2019
Decoding capital expenditure
Research Desk . 08-Nov-2018
The pledge tracker
Research Desk . 05-Jul-2018
Eight For 2007
Value Research . 01-Feb-2007
In Focus: Right Prescription
Value Research . 01-Sep-2006

News & Announcements